Your Current Location : Fund Card : Fund Summary |
|
|
|
Aditya Birla SL Pharma & Healthcare Fund (G) Direct |
|
[Equity: Sectoral] |
|
|
|
Fund Details |
Fund Type |
Growth |
Launch Date |
20 Jun 2019 |
Corpus(Cr.) |
692.0 |
Scheme NAV |
28.36 |
Equity(%) |
93.05 |
52 Week High |
29.1 |
Debt(%) |
6.95 |
52 Week Low |
17.97 |
Others(%) |
0.0 |
Exit Load |
1% for redemption Within 30 days |
Minimum Investment |
- |
Availability |
Open |
Entry Load |
- |
Expense Ratio(%) |
1.02 |
Scheme Benchmark |
S&P BSE Healthcare TRI |
Broader Benchmark |
NSE - Nifty 50 TRI |
|
|
Scheme Objective |
Investment Strategy The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. |
|
|
|
|
|
|
|
|
|
|
|
|